Professional Documents
Culture Documents
Adrenergic receptor
The adrenergic receptors (or adrenoceptors) are a class of G protein-coupled receptors that are targets of the catecholamines, especially norepinephrine (noradrenaline) and epinephrine (adrenaline). Many cells possess these receptors, and the binding of a catecholamine to the receptor will generally stimulate the sympathetic nervous system. The sympathetic nervous system is responsible for the fight-or-flight response, which includes widening the pupils of the eye, mobilizing energy, and diverting blood flow from nonessential organs to skeletal muscle.
Naghman Zuberi
Categories
There are two main groups of adrenergic receptors, and , with several subtypes. receptors have the subtypes 1 (a Gq coupled receptor) and 2 (a Gi coupled receptor). Phenylephrine is a selective agonist of the receptor. receptors have the subtypes 1, 2 and 3. All three are linked to Gs proteins (although 2 also couples to Gi),which in turn are linked to adenylate cyclase. Agonist binding thus causes a rise in the intracellular concentration of the second messenger cAMP. Downstream effectors of cAMP include cAMP-dependent protein kinase (PKA), which mediates some of the intracellular events following hormone binding. Isoprenaline is a non-selective agonist.
Naghman Zuberi
Naghman Zuberi
Type 1
Acts by phospholipase C activation, which forms IP3 and DAG In blood vessels these cause vasoconstriction Blood vessels with alpha-1 receptors are present in the skin and the genitourinary system, and during the fight-or-flight response there is decreased blood flow to these organs Acts by inactivation of adenylate cyclase, cyclic AMP levels within the cell decrease These are found on pre-synaptic nerve terminals
Type 2
Naghman Zuberi
Location Function
Post junctional Stimulatory GU, Vasoconstriction, gland secretion, Gut relaxation, Glycogenolysis Phenylephrine, Methoxamine
Prejunctional
Inhibition of transmitter release, vasoconstriction, decreased central symp. Outflow, platelet aggregation Clonidine
Agonist
Antagonist Prazosin
Yohimbine
Naghman Zuberi
Eye -- Mydriasis Arterioles Constriction Uterus -- Contraction Skin -- Sweat Platelet - Aggregation Male ejaculation Hyperkalaemia Bladder Sphincter Contraction 2 adrenoceptors on nerve endings mediate negative feedback which inhibits noradrenaline release
7
Naghman Zuberi
Beta receptors
All receptors activate adenylate cyclase, raising the intracellular cAMP concentration Type 1:
Type 2:
These are present in heart tissue, and cause an increased heart rate by acting on the cardiac pacemaker cells
Type 3:
These are in the vessels of skeletal muscle, and cause vasodilatation, which allows more blood to flow to the muscles, and reduce total peripheral resistance Stimulated by adrenaline, but not noradrenaline Beta-2 receptors are also present in bronchial smooth muscle, and cause bronchodilatation when activated Bronchodilator salbutamol work by binding to and stimulating the 2 receptors
Beta-3 receptors are present in adipose tissue and are thought to have a role in the regulation of lipid metabolism
Naghman Zuberi
Beta-2
Bronchi, uterus, Blood vessels, urinary tract, eye Salbutamol Alpha-methyl propranolol Weak
Beta-3
Adipose tissue
Agonist
Dobutamine
Moderate
Strong
9
Bronchi -- Relaxation Arterioles -- Dilatation Uterus Relaxation Skeletal Muscle - Tremor Hypokalaemia Hepatic Glycogenolysis
Naghman Zuberi
10
Dopamine receptors
D1-receptors are post synaptic receptors located in blood vessels and CNS
D2-receptors are presynaptic present in CNS, ganglia, renal cortex
Naghman Zuberi
11
Noradrenergic transmission
Nor-adrenaline is the major neurotransmitter of the Sympathetic system Noradrenergic neurons are postganglionic sympathetic neurons with cell bodies in the sympathetic ganglia They have long axons which end in varicosities where NA is synthesized and stored
12
Naghman Zuberi
Adrenergic transmission
Catecholamines: Natural: Adrenaline, Noradrenaline, Dopamine Synthetic: Isoprenaline, Dobutamine Non-Catecholamines:
Also called sympathomimetic amines as most of them contain an intact or partially substituted amino (NH2) group
13
Naghman Zuberi
Biosynthesis of Catecholamines
Phenylalanine
PH
Alpha-methyl-ptyrosine
Naghman Zuberi
14
Storage of Noradrenaline
Naghman Zuberi
15
Naghman Zuberi
16
Regulators of NA release
Naghman Zuberi
17
Uptake of Catecholamines
Naghman Zuberi
18
Reuptake
Sympathetic nerves take up amines and release them as neurotransmitters Uptake I is a high efficiency system more specific for NA
Located in smooth muscle/ cardiac muscle Inhibited by steroids/ phenoxybenzamine No Physiological or Pharmacological importance
Naghman Zuberi
19
Metabolism of CAs
Intracellular bound to mitochondrial membrane Present in NA terminals and liver/ intestine MAO inhibitors are used as antidepressants
Catechol-o-methyl-transferase (COMT)
Neuronal and non-neuronal tissue Acts on catecholamines and byproducts VMA Naghman Zuberi levels are diagnostic for tumours
20
Metabolism of CAs
(Homovanillic acid)
(Vanillylmandelic acid)
Naghman Zuberi
21
Dopamine receptors
D1-receptors are post synaptic receptors located in blood vessels and CNS
D2-receptors are presynaptic present in CNS, ganglia, renal cortex
Naghman Zuberi
22
Adrenaline as prototype
Potent stimulant of alpha and beta receptors Complex actions on target organs
Naghman Zuberi
23
Blood Pressure
Most potent vasopressor known Both systolic and Diastolic BP rise Has a characteristic effect on BP Rapid rise to a peak:
+ve ionotropic
+ve chronotropic Vasoconstriction which leads to increased peripheral resistance Reflex Bradycardia
Naghman Zuberi
24
Blood Vessels
Seen mainly in the smaller vessels - arterioles Decreased blood flow to skin and mucus membranes alpha effect Increased blood flow to skeletal muscles- (Beta2 effect) counterbalanced by a vasoconstrictor effect of alpha receptors If alpha receptors are blocked there is no opposing effect and this leads to fall of BP
25
Naghman Zuberi
Heart
Powerful Cardiac stimulant Acts on beta-1 receptors in myocardium, pacemaker cells and conducting tissue
Heart rate increases Rhythm is altered Cardiac systole is shorter and more powerful Cardiac output is enhanced Oxygen consumption is increased Cardiac efficiency is markedly decreased
26
Naghman Zuberi
Actions of Adrenaline
Respiratory: Powerful bronchodilator Relaxes bronchial smooth muscle Beta-2 mediated effect Physiological antagonist to mediators of bronchoconstriction e.g. Histamine Smooth Muscles: Effects on vascular smooth muscle are important GIT and Urinary tract smooth muscle are relaxed but are clinically unimportant In the pregnant uterus there is inhibition of tone and contractions Naghman Zuberi
27
Metabolic effects
Increases concentration of glucose and lactic acid Calorigenesis (-2 and -3) Inhibits insulin secretion (-2) Decreases uptake of glucose by peripheral tissue Simulates glycogenolysis - Beta effect Increases free fatty acid concentration in blood
Naghman Zuberi
28
ADME
Ineffective orally Absorbed slowly from subcutaneous tissue Faster from IM site Inhalation is locally effective Not usually given IV Rapidly inactivated in Liver by MAO and COMT
29
Naghman Zuberi
Injectable preparations are available in dilutions 1:1000, 1:10000 and 1:100000 Usual dose is 0.3-0.5 mg sc of 1: 10000 solution Used in:
Anaphylactic shock Prolong action of local anaesthetics Cardiac arrest Topically, to stop bleeding
Naghman Zuberi
30
Naghman Zuberi
31
Noradrenaline
Neurotransmitter released from postganglionic adrenergic nerve endings (80%) Orally ineffective and poor SC absorption IV administered Metabolized by MAO, COMT Short duration of action
32
Naghman Zuberi
Agonist at 1, 2 and 1 Adrenergic receptors Equipotent on 1, but No effect on 2 Increases systolic, diastolic B.P, mean pressure, pulse pressure and stroke volume Total peripheral resistance (TPR) increases due to vasoconstriction Decreases blood flow to kidney, liver and skeletal muscles Increases coronary blood flow Uses: Injection Noradrenal bitartrate slow IV infusion at the rate of 2-4mg/ minute used as a vasopressor agent in treatment of hypovolemic shock and other hypotensive states in order to raise B.P
Naghman Zuberi
33
Anxiety, palpitation, respiratory difficulty Rise of B.P, headache Extravasations causes necrosis, gangrene Contracts gravid uterus Severe hypertension, violent headache, photophobia, anginal pain, pallor and sweating in hyperthyroid and hypertensive patients
34
Naghman Zuberi
Dopamine
Immediate metabolic precursor of Noradrenalin High concentration in basal ganglia, limbic system and hypothalamus Central neurotransmitter, regulates body movements ineffective orally, IV use only, Short T 1/2 (3-5minutes)
35
Naghman Zuberi
Dopamine
Naghman Zuberi
36
Dopamine
In small doses 2-5g/kg/minute, it stimulates D1-receptors in renal, mesenteric and coronary vessels leading to vasodilatation
Naghman Zuberi
Dopamine
Moderate dose (5-10 g/kg/minute), stimulates 1-receptors in heart producing positive inotropic and chronotropic actions actions Releases Noradrenaline from nerves by 1stimulation Does not change TPR and HR Great Clinical benefit in CVS shock and CCF High dose (10-30 g/kg/minute), stimulates vascular adrenergic 1-receptors vasoconstriction and decreased renal blood flow
38
Naghman Zuberi
Nasal Decongestants:
Naghman Zuberi
39
-2 Adrenergic agonists
Salbutamol Terbutaline Salmeterol Reproterol Oxiprenaline Fenoterol Isoxsuprine Rimiterol Ritodrine Bitolterol Isoetharine
40
Naghman Zuberi
Phenylepherine
Selective, synthetic and direct 1 agonist Administered parenteraly & topically (eye, nose) Long duration of action Resistant to MAO and COMT Peripheral vasoconstriction leads to rise in BP Reflex bradycardia Produces mydriasis and nasal decongestion Used in hypovolaemic shock as pressor agent Sinusitis & Rhinitis as nasal decongestant Mydriatic in the form of eye drops and lowers intraocular pressure Does not cross BBB, so no CNS effects Actions qualitatively similar to noradrenaline ADRs: Photosensitivity, conjunctival hyperemia and hypersensitivity
41
Naghman Zuberi
Ephedrine
Plant alkaloid, indirect sympathomimetic actions resembling adrenaline peripherally Centrally Increased alertness, anxiety, insomnia, tremor and nausea in adults. Sleepiness in children Effects appear slowly but lasts longer (t1/2-4h) achyphylaxis on repeated dosing Used as bronchodilator, mydriatic, in heart block, mucosal vasoconstriction & in myasthenia gravis. Pseudoephedrine is similar Phenylpropanolamine(PPA) on prolonged administration to woman as anorectic causes pulmonary valve abnormality
42
Naghman Zuberi
Nasal and bronchial decongestants are used in allergic rhinitis, colds, coughs and sinusitis as nasal drops Sympathomimetic vasoconstrictors with - effects are used Mucosal ischaemic damage occurs if used excessively (more often than 3hrly) or for prolonged periods (>3weeks) Rebound congestion leads to overuse Use ephedrine, phenylepherine, xylometazoline for only a few days since longer application reduces ciliary action Do not use Naphazoline and Adrenaline Do not use mixtures of vasoconstrictor, antihistaminic, adrenal steroid & antibiotic Oily drops & sprays may cause lipoid pneumonia They lead to failure of antihypertensive therapy Fatal hypertensive crisis in patients on MAOIs
43
Naghman Zuberi
Clonidine
Naghman Zuberi
Agonist to postsynaptic 2A adrenoceptors in brain, stimulation suppresses sympathetic outflow and reduces blood pressure High dose activates peripheral presynaptic autoreceptors on adrenergic nerve ending mediating negative feedback suppression of noradrenaline release Overdose stimulates peripheral postsynaptic 1 adrenoceptors & cause hypertension by vasoconstriction Clonidine reduces blood pressure
44
Clonidine contd.
Abrupt or gradual withdrawal causes rebound hypertension Onset may be rapid (a few hours) or delayed for as long as 2 days and subsides over 2-3 days Never use Clonidine with -adrenoceptor blockers
Naghman Zuberi
45
Clonidine - ADRs
Sedation, dry mouth TCAs antagonize antihypertensive action & increase rebound hypertension of abrupt withdrawal Low dose Clonidine (50-100g/dl) is used in migraine prophylaxis, menopausal flushing and chorea Moxonidine, Rilmenidine Newer Imidazolines
46
Naghman Zuberi
2 Adrenergic Agonists
Short acting : Salbutamol, Metaproterenol, Terbutaline, pirbuterol Selective for 2 receptor subtype Used for acute inhalational treatment of bronchospasm. Onset of action within 1 to 5 minutes Bronchodilatation lasts for 2 to 6 hours Duration of action longer on oral administration Directly relax airway smooth muscle Relieve dyspnoea of asthmatic bronchoconstriction Long acting: Salmeterol, Bitolterol, colterol Naghman Zuberi
47
Uterine Relaxants
Antioxytocics or tocolytic agents 2 agonists relax uterus Used by i.v. infusion to inhibit premature labour Isoxsuprine, Terbutaline, Ritodrine, Salbutamol Tachycardia & hypotension occur Use minimum fluid volume using 5% dextrose as diluents Ritodrine 50 g/min, increase by 50 g/min every 10 minutes until contractions stop or maternal heart rate is 140 beats/minute. Continue for 12-48 hours after contractions stop
Naghman Zuberi
48
What to Remember ?
Biosynthesis of Catecholamine Distribution of adrenergic receptors Functions of Adrenergic receptors Pharmacological actions of adrenaline Dopamine/Dobutamine actions Nasal decongestants Tocolytic drugs (Uterine Relaxants)
49
Naghman Zuberi
Alfa-adrenoblockers
Naghman Zuberi
50
Phentolamine, tropaphen
are synthetic 1, 2-drenoblockers
administration
diagnostics and symptomatic treatment of feochromocytoma disturbances of peripheral blood circulation in case of endarteriitis, Reinos disease, trophic ulcers, decubitus complex treatment of hypertensive crises, acute cardiac insufficiency complex therapy of hypovolemic and cardiogenic shock
Naghman Zuberi 51
Prasosin
Selective 1- adrenoblocker
Administration
treatment of arterial hypertension Side effects
phenomenon of first dose: sudden decreasing of blood pressure and even development of orthostatic collapse after first administrations of the drug Prophylaxis: administration of half-dose before sleep
Naghman Zuberi 52
Beta-adrenoblockers
Naghman Zuberi
53
Mechanism for How It WorksBeta-blockers "block" the effects of adrenaline on your body's beta-receptors. This slows the nerve impulses that travel through the heart. As a result, your heart does not have to work as hard because it needs less blood and oxygen. This decreases heart rate, blood pressure, and lessens the need for nitrates. Beta-blockers also block the impulses that can cause an arrhythmia (abnormal heart beat). Beta-blockers generally work by affecting the response to some nerve impulses. Your body has 2 main beta-receptors: beta 1 and beta 2. Some beta-blockers are selective, which means that they block beta 1 receptors more than they block beta 2 receptors. Beta 1 receptors are responsible for heart rate and the strength of your heartbeat. Nonselective beta-blockers block both beta 1 and beta 2 receptors. Beta 2 receptors are responsible for the function of your smooth muscles (muscles that control body functions but that you do not have control over). This class of drugs may decrease the sympathetic outflow from the central nervous system and/or suppress the release of renina substance that is elevated in some patients with high blood pressure and is involved in a cascade of events leading to constriction of blood vessels. In addition, some speculate that beta-blockers may have possible antioxidant and cholesterol lowering effects.
Naghman Zuberi
54
Block alpha & beta receptor sites (nonselective) direct or indirect acting on the release of norepinephrine and epinephrine Uses - Cardiac arrthymias ( HR), HTN ( cardiac output), angina ( O2 demand) Side Effects - CHF, bronchospasm, bradycardia, wheezing
55
Naghman Zuberi
Nonselective have an equal inhibitory effect on B1 & B2 receptors - Drugs have lots of interactions due to lots of alpha/beta receptor sites throughout body - use with caution on clients with cardiac failure or asthma Selective B1 helpful in asthma clients
Naghman Zuberi
56
Anaprilin
Is a 1- 2-adrenoblocker
Administration
ischemic heart disease arterial hypertension cardiac tachyarrhythmias acute myocardium infarction
Naghman Zuberi 57
Talinolol or cordanum
is a cardioselective -adrenoblocker
Administration
.
Naghman Zuberi
Atenolol (tenormin)
Indications for administration
ischemic heart disease arterial hypertension cardiac arrhythmias acute myocardium infarction
Naghman Zuberi 59
Acebutolol (sectral)
1-adrenoblocker with inner sympathomimetic activity
Indications
disorders of cardiac rhythm (tachyarrhythmias) hypertension ischemic heart disease
Naghman Zuberi 60
Labetolol
-, -adrenoblocker. The drug blocks 1, 2, 1 and 2-adrenoreceptors
Administration
treatment of patients with arterial hypertension hypertensive crisis
Contraindications
Atrio-ventricular blockade, cardiac insufficiency
Naghman Zuberi 61
CARVEDILOL, NEBIVOLOL
increase the production of Nitric Oxide in blood vessels. They are used now for chronic cardiac insufficiency (congestive heart failure)
Naghman Zuberi
62
Nebivolol
Nebilet
Naghman Zuberi
63
Sympatholytics
Naghman Zuberi
64
Reserpine
is a sum of Rauvolfia (plant) alkaloids. Maximal hypotensive action develops after 5-7 days of regular administration of the drug. After the treatment coarsed effect can still stay for two weeks.
Reserpin
treatment of different forms of essential hypertension (drugs of a second row, second line) (combined drugs trirezid, cristepin, adelfan, brinerdin)
Administration
Side effects
manifestations of parkinsonism fatigue, somnolence, depression, bradycardia increasing of motor and secretory activity of gastrointestinal tract, acute attacks of ulcer disease, diarrhea swelling of nose mucous membrane with complication of nose breathing
Naghman Zuberi
66
Octadin
Is a sympatholytic with strong hypotensive effect. During administration of the drug decreasing of blood pressure develops gradually, after 2-3 days. After abolition of drug administration the effect still stays for 2 weeks.
Administration
heavy forms of arterial hypertension
Side effects
general weakness, nausea, vomiting, swelling of nose mucous membrane, diarrhea, liquid retention in the organism, orthostatic collapse
Naghman Zuberi 67